184 related articles for article (PubMed ID: 34274492)
1. Safety and Tolerability of SARS-CoV2 Emergency-Use Authorized Vaccines for Allogeneic Hematopoietic Stem Cell Transplant Recipients.
Ali H; Ngo D; Aribi A; Arslan S; Dadwal S; Marcucci G; Nakamura R; Forman SJ; Chen J; Al Malki MM
Transplant Cell Ther; 2021 Nov; 27(11):938.e1-938.e6. PubMed ID: 34274492
[TBL] [Abstract][Full Text] [Related]
2. Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients.
Canti L; Humblet-Baron S; Desombere I; Neumann J; Pannus P; Heyndrickx L; Henry A; Servais S; Willems E; Ehx G; Goriely S; Seidel L; Michiels J; Willems B; Liston A; Ariën KK; Beguin Y; Goossens ME; Marchant A; Baron F
J Hematol Oncol; 2021 Oct; 14(1):174. PubMed ID: 34689821
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of mRNA1273 SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Single center experience.
Huguet M; Boigues M; Sorigué M; Blanco J; Quirant B; Ferrà C; ;
Med Clin (Barc); 2024 Apr; 162(7):313-320. PubMed ID: 38000941
[TBL] [Abstract][Full Text] [Related]
4. The effect of gastrointestinal graft-versus-host disease and diarrhea on the pharmacokinetic profile of sotrovimab in hematopoietic stem cell transplant recipients.
Boonyaratanakornkit J; Wang Q; Nader A; Kimball L; Stevens-Ayers T; Levkova M; Blazevic R; Nguyen J; Wright J; Castor J; Greninger AL; Ford E; Mielcarek M; Fordred S; Han J; Boeckh M; Waghmare A
J Infect Dis; 2024 May; ():. PubMed ID: 38743457
[TBL] [Abstract][Full Text] [Related]
5. Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID-19 prevention.
Trepl J; Pasin C; Schneidawind D; Mueller NJ; Manz MG; Bankova AK; Abela IA
Br J Haematol; 2024 May; 204(5):1908-1912. PubMed ID: 38327109
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: Concerns.
Daungsupawong H; Wiwanitkit V
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1111. PubMed ID: 38679969
[No Abstract] [Full Text] [Related]
7. A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature.
Bailey AJM; Kirkham AM; Monaghan M; Shorr R; Buchan CA; Bredeson C; Allan DS
Curr Oncol; 2022 Jan; 29(1):337-349. PubMed ID: 35049704
[TBL] [Abstract][Full Text] [Related]
8. AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update.
Sultan S; Siddique SM; Singh S; Altayar O; Caliendo AM; Davitkov P; Feuerstein JD; Kaul V; Lim JK; Mustafa RA; Falck-Ytter Y; Inadomi JM;
Gastroenterology; 2021 Sep; 161(3):1011-1029.e11. PubMed ID: 34029569
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Challenges in COVID-19.
Maiti AK
Curr Mol Med; 2024; 24(1):14-25. PubMed ID: 36567277
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection.
Seng MS; Ng KP; Soh TG; Tan TT; Chan M; Maiwald M; Tan LK; Linn YC; Leung W
Cytotherapy; 2024 May; ():. PubMed ID: 38864802
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV2 infections in heart transplant recipients: Vaccines still are our greatest weapon.
Tedeschi A; Gentile P; Palazzini M; Masciocco G; Leidi F; Monticelli M; Ammirati E; Garascia A
Int J Cardiol Heart Vasc; 2024 Apr; 51():101379. PubMed ID: 38628295
[No Abstract] [Full Text] [Related]
12. Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection.
Nimgaonkar I; Flaherty PW; Oshima MU; Hill JA
Clin Infect Dis; 2024 Jun; ():. PubMed ID: 38833622
[No Abstract] [Full Text] [Related]
13. Pidotimod in Paucisymptomatic SARS-CoV2 Infected Patients.
Ucciferri C; Barone M; Vecchiet J; Falasca K
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020048. PubMed ID: 32670526
[No Abstract] [Full Text] [Related]
14. "Strategies of liver transplantation during the second wave - based on lessons learnt from the first wave of the SARS- COV2 pandemic".
Singh SA; Khurana S; Jadaun SS; Gupta S; Saigal S
J Liver Transpl; 2021; 2():100015. PubMed ID: 38620730
[No Abstract] [Full Text] [Related]
15. Abnormal liver blood tests among hospitalised patients with SARS-CoV2 (COVID-19).
Ruiz P; Cardenas A
Frontline Gastroenterol; 2021; 12(2):87-88. PubMed ID: 33617604
[No Abstract] [Full Text] [Related]
16. Correspondence Regarding "Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors".
Takada K; Takamori S; Miura N; Shikada Y; Shimokawa M
JTO Clin Res Rep; 2021 Nov; 2(11):100238. PubMed ID: 34870248
[No Abstract] [Full Text] [Related]
17. Serologic Responses following a Single Dose of SARS-Cov-2 Vaccination in Allogeneic Stem Cell Transplantation Recipients.
Easdale S; Shea R; Ellis L; Bazin J; Davis K; Dallas F; Thistlethwayte E; Ethell M; Potter M; Arias C; Anthias C; Nicholson E
Transplant Cell Ther; 2021 Oct; 27(10):880.e1-880.e4. PubMed ID: 34293520
[TBL] [Abstract][Full Text] [Related]
18. Administration of COVID-19 vaccines in immunocompromised patients.
Negahdaripour M; Shafiekhani M; Moezzi SMI; Amiri S; Rasekh S; Bagheri A; Mosaddeghi P; Vazin A
Int Immunopharmacol; 2021 Oct; 99():108021. PubMed ID: 34352567
[TBL] [Abstract][Full Text] [Related]
19. Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant.
Atanackovic D; Luetkens T; Avila SV; Hardy NM; Lutfi F; Sanchez-Petitto G; Vander Mause E; Glynn N; Mannuel HD; Alkhaldi H; Hankey K; Baddley J; Dahiya S; Rapoport AP
Vaccines (Basel); 2021 Jul; 9(7):. PubMed ID: 34358153
[TBL] [Abstract][Full Text] [Related]
20. Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy.
Dhakal B; Abedin S; Fenske T; Chhabra S; Ledeboer N; Hari P; Hamadani M
Blood; 2021 Oct; 138(14):1278-1281. PubMed ID: 34339501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
